Summary

The global medical device contract manufacturing market is projected to reach USD 135.47 billion in 2031 from USD 85.59 billion in 2026, at a 9.6% CAGR between 2026 and 2031. Rising technological advancements in medical devices, along with an increasing geriatric population, are expected to drive the market. The market is anticipated to grow due to continuous developments in medical fields such as robotics and minimally invasive surgery, artificial intelligence (AI) in medical devices, telemedicine, and remote patient monitoring. An aging population and rising demand for medical diagnostics further contribute to market growth. However, strict regulatory compliance and supply chain complexities are expected to limit market growth to some extent.

By device type, the diabetes care devices segment is expected to witness the highest CAGR in the medical device contract manufacturing market.
The diabetes care devices segment is projected to experience the highest CAGR in the medical device contract manufacturing market from 2026 to 2031. This growth is driven by increasing demand for advanced diabetes management devices, including continuous glucose monitoring systems, insulin delivery devices, insulin pens, and other connected solutions. The growing complexity of these devices is encouraging diabetes care companies to outsource manufacturing activities to specialized contract manufacturers with expertise in precision components, electronics integration, automated assembly, and high-volume production. The increasing adoption of connected and wearable diabetes devices is further creating opportunities for contract manufacturers to support product development, NPI, assembly, testing, and commercial-scale manufacturing.

The device development & manufacturing services segment accounted for the largest share of the market in 2025, by service.
The device development & manufacturing services segment commands the largest market share in the medical device contract manufacturing sector, largely because it transforms concepts into viable medical devices. Smaller enterprises and mid-sized firms often outsource these services to reduce costs, speed product timelines, and leverage specialized knowledge and advanced manufacturing techniques. This segment covers the entire product development lifecycle, from initial design and prototyping to large-scale commercialization, making it crucial for both emerging and established companies. Furthermore, escalating demand for sophisticated, high-precision medical instruments—such as minimally invasive surgical devices and wearable health monitoring technologies—has significantly increased the need for comprehensive manufacturing partnerships, further solidifying this segment's market prominence.

Asia Pacific accounted for the largest market share in 2025.
The Asia Pacific (APAC) region is experiencing a significant surge in demand for medical device contract manufacturing services, driven by several key factors. First, rapid population growth in many countries in the region is increasing the need for advanced medical solutions. Additionally, growing awareness among healthcare providers and patients of the benefits and capabilities of modern medical devices further fuels this demand. The expanding middle class in various Asia Pacific nations is also contributing to this trend, as more consumers gain access to healthcare services and products. As a result, global leaders in the medical device contract manufacturing sector are actively establishing and expanding operations in the Asia Pacific market. These companies are introducing a variety of cutting-edge medical devices, innovative software solutions, and a diverse range of biocompatible materials tailored to different healthcare settings. In particular, China is set to dominate the APAC medical device contract manufacturing market, and it is projected to capture the largest share in 2024. This growth can be attributed to the increasing prevalence of chronic diseases, along with greater public and institutional awareness of the availability and efficacy of medical devices. As a result, the Asia Pacific region has accounted for the largest share of the market, driven by these interconnected trends and the continued evolution of the healthcare landscape.

Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
- By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Demand-side:
- By End User: Medical Device Manufacturers (50%), Pharmaceutical & Drug Delivery Companies (33%), and Diagnostic Companies (17%)
- By Designation: Procurement/Purchasing Managers (47%), R&D/Product Development Heads (22%), Manufacturing/Engineering Heads (15%), and Others (16%)
- By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and Middle East & Africa (15%)

Research Coverage
The report examines the medical device contract manufacturing market and estimates market size and future growth potential across segments, including device type, device class, service, and region. It also includes a competitive analysis of major players, highlighting company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report helps established companies and newer or smaller firms understand market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:
- Analysis of key drivers (growth in the medical devices market in developing countries, adoption of robotics and automation in manufacturing, technological advancements in medical device modalities, and the impact of Industry 4.0 on the medical device industry), restraints (consolidation in the medical devices market), opportunities (increasing healthcare expenditure, infrastructure, and awareness in developing economies, and a rising geriatric population and its associated diseases), and challenges (lack of constant innovation to balance technological capabilities against costs).
- Market Penetration: It includes extensive information on product portfolios offered by the major players in the global medical device contract manufacturing market. The report includes various segments in market device type, class of device, service, and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical device contract manufacturing market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by device type, class of device, service, and region.
- Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global medical device contract manufacturing market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global medical device contract manufacturing market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 STUDY SCOPE 39
1.3.1 MARKETS COVERED & REGIONAL SCOPE 39
1.3.2 INCLUSIONS & EXCLUSIONS 40
1.3.3 YEARS CONSIDERED 40
1.4 CURRENCY 40
1.5 STAKEHOLDERS 41
1.6 SUMMARY OF CHANGES 41

2 EXECUTIVE SUMMARY 43
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 43
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 44
2.3 DISRUPTIVE TRENDS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 45
2.4 HIGH-GROWTH SEGMENTS 46
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 47

3 PREMIUM INSIGHTS 49
3.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW 49
3.2 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET,
BY SERVICE AND COUNTRY (2025) 50
3.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET:
GEOGRAPHIC GROWTH OPPORTUNITIES 51
3.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGION (2026−2031) 51
3.5 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED VS.
DEVELOPING ECONOMIES 52

4 MARKET OVERVIEW 53
4.1 INTRODUCTION 53
4.2 MARKET DYNAMICS 54
4.2.1 DRIVERS 54
4.2.1.1 Growing medical devices market in developing countries 54
4.2.1.2 Adoption of robotics and automation in manufacturing 55
4.2.1.3 Technological advancements in medical device modalities 56
4.2.1.4 Impact of Industry 4.0 on medical device industry 58
4.2.1.5 Growing emphasis on patient convenience driving demand for specialized medical device contract manufacturing 59
4.2.2 RESTRAINTS 59
4.2.2.1 Intellectual property and confidentiality concerns 59
4.2.2.2 Pricing pressure from OEM customers 60
4.2.3 OPPORTUNITIES 61
4.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing economies 61
4.2.3.2 Rising geriatric population and increasing incidence of associated diseases 61
4.2.4 CHALLENGES 62
4.2.4.1 Lack of constant innovation to balance technological capabilities against costs 62
4.2.4.2 Balancing cost reduction with quality 63
4.3 UNMET NEEDS & WHITE SPACES 63
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 64
4.4.1 INTERCONNECTED MARKETS 64
4.4.2 CROSS-SECTOR OPPORTUNITIES 65
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65
4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65

5 INDUSTRY TRENDS 66
5.1 PORTER’S FIVE FORCE ANALYSIS 66
5.1.1 THREAT OF NEW ENTRANTS 67
5.1.2 THREAT OF SUBSTITUTES 68
5.1.3 BARGAINING POWER OF SUPPLIERS 68
5.1.4 BARGAINING POWER OF BUYERS 68
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.2 MACROECONOMIC INDICATORS 69
5.2.1 INTRODUCTION 69
5.2.2 GDP TRENDS & FORECAST 69
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 71
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE CONTRACT MANUFACTURING INDUSTRY 72
5.3 VALUE CHAIN ANALYSIS 73
5.4 ECOSYSTEM ANALYSIS 74
5.5 PRICING ANALYSIS 75
5.5.1 AVERAGE SELLING PRICE TREND IN MEDICAL DEVICE CONTRACT MANUFACTURING, BY KEY PLAYER, 2023–2025 75
5.5.1.1 Average selling price trend in medical device contract manufacturing (drug delivery devices, cardiovascular devices, and IVD devices), by key player, 2023–2025 75
5.5.2 AVERAGE SELLING PRICE TREND IN MEDICAL DEVICE CONTRACT MANUFACTURING, BY REGION, 2023–2025 76
5.5.2.1 Average selling price trend of drug delivery devices, by region, 2023−2025 76
5.5.2.2 Average selling price trend of IVD devices, by region, 2023−2025 77
5.5.2.3 Average selling price trend of cardiovascular devices, by region, 2023−2025 77
5.6 TRADE ANALYSIS 78
5.6.1 IMPORT DATA FOR HS CODE 9018, 2021–2025 78
5.6.2 EXPORT DATA FOR HS CODE 9018, 2021–2025 79
5.7 KEY CONFERENCES & EVENTS, 2026–2027 80
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
5.9 INVESTMENT & FUNDING SCENARIO 82
5.10 CASE STUDY ANALYSIS 82
5.10.1 CASE STUDY 1: JABIL INC. AND AMS OSRAM PARTNER TO ACCELERATE POINT-OF-CARE DIAGNOSTIC TESTING 82
5.10.2 CASE STUDY 2: SANMINA AND MEDICAL DIAGNOSTICS COMPANY PARTNER FOR RAPID NPI AND MANUFACTURING 83
5.10.3 CASE STUDY 3: PLEXUS AND QUIDEL COLLABORATE TO SCALE POINT-OF-CARE DIAGNOSTIC MANUFACTURING 83
5.11 IMPACT OF 2025 US TARIFFS ON MEDICAL DEVICE CONTRACT
MANUFACTURING MARKET 83
5.11.1 INTRODUCTION 83
5.11.2 KEY TARIFF RATES 84
5.11.3 PRICE IMPACT ANALYSIS 85
5.11.4 IMPACT ON COUNTRY/REGION 86
5.11.4.1 NORTH AMERICA 86
5.11.4.2 ASIA PACIFIC 86
5.11.4.3 EUROPE 87
5.11.4.4 LATIN AMERICA 88
5.11.5 IMPACT ON END-USE INDUSTRIES 88

6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS,
AND DIGITAL & AI ADOPTION 89
6.1 TECHNOLOGY ANALYSIS 89
6.1.1 KEY EMERGING TECHNOLOGIES 89
6.1.1.1 Additive manufacturing/3D printing 89
6.1.1.2 Advanced laser micromachining and processing 89
6.1.2 COMPLEMENTARY TECHNOLOGIES 90
6.1.2.1 Digital twins 90
6.1.2.2 IIOT 90
6.1.3 ADJACENT TECHNOLOGIES 91
6.1.3.1 Nitinol & shape-memory materials for advanced medical devices 91
6.2 TECHNOLOGY/PRODUCT ROADMAP 91
6.3 FUTURE APPLICATIONS 92
6.3.1 PERSONALIZED & PATIENT-SPECIFIC MEDICAL DEVICES 93
6.3.2 MINIMALLY INVASIVE & COMPLEX DEVICES 93
6.3.3 CONNECTED AND SMART MEDICAL DEVICES 93
6.3.4 AI-ENABLED & DIGITAL MANUFACTURING 93
6.4 IMPACT OF AI/GENERATIVE AI ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 93
6.4.1 INTRODUCTION 93
6.4.2 MARKET POTENTIAL IN MEDICAL DEVICE CONTRACT MANUFACTURING ECOSYSTEM 93
6.4.3 AI USE CASES 94
6.4.4 KEY COMPANIES IMPLEMENTING AI IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 94

7 SUSTAINABILITY & REGULATORY LANDSCAPE 96
7.1 REGULATORY LANDSCAPE 96
7.1.1 REGULATORY FRAMEWORK 96
7.1.1.1 North America 96
7.1.1.1.1 US 96
7.1.1.1.2 Canada 97
7.1.1.2 Europe 97
7.1.1.3 Asia Pacific 98
7.1.1.3.1 Japan 98
7.1.1.3.2 China 99
7.1.1.3.3 India 99
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
7.2 SUSTAINABILITY INITIATIVES 102
7.2.1 ENERGY-EFFICIENT MANUFACTURING & CARBON REDUCTION IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 102
7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 103
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 103

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 105
8.1 KEY STAKEHOLDERS & BUYING CRITERIA 105
8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 105
8.1.2 BUYING CRITERIA 106
8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 107
8.2.1 DECISION-MAKING PROCESS 107
8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 108
8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109
8.2.4 MARKET PROFITABILITY 110

9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE 111
9.1 INTRODUCTION 112
9.2 IVD DEVICES 113
9.2.1 IVD CONSUMABLES 115
9.2.1.1 Increasing demand for reagents & kits to drive market 115
9.2.2 IVD EQUIPMENT 117
9.2.2.1 Advancements in diagnostic technologies to support market growth 117
9.3 DIAGNOSTIC IMAGING DEVICES 119
9.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO AUGMENT MARKET 119
9.4 CARDIOVASCULAR DEVICES 121
9.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET 121
9.5 DRUG DELIVERY DEVICES 123
9.5.1 INFUSION DEVICES & ADMINISTRATION SETS 125
9.5.1.1 Rising incidence of chronic diseases and growing number of surgical procedures to fuel market 125
9.5.2 SYRINGES 127
9.5.2.1 High cost of safety syringes and increasing incidence of needlestick injuries to hinder market 127
9.5.3 INHALERS 129
9.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market growth 129
9.5.4 AUTOINJECTORS 131
9.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements to drive market 131
9.5.5 PEN INJECTORS 133
9.5.5.1 Rising prevalence of chronic diseases and growing pipeline of biologics and biosimilars to boost market growth 133
9.5.6 OTHER DRUG DELIVERY DEVICES 134
9.6 ORTHOPEDIC DEVICES 136
9.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET 136
9.7 RESPIRATORY CARE DEVICES 138
9.7.1 GROWING PREVALENCE OF RESPIRATORY INFECTIONS TO DRIVE MARKET 138
9.8 OPHTHALMOLOGY DEVICES 140
9.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET 140
9.9 SURGICAL DEVICES 142
9.9.1 INCREASE IN SURGICAL PROCEDURES TO FUEL MARKET 142
9.10 DIABETES CARE DEVICES 144
9.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET 144
9.11 DENTAL DEVICES 146
9.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET 146
9.12 ENDOSCOPY & LAPAROSCOPY DEVICES 148
9.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET 148
9.13 GYNECOLOGY/UROLOGY DEVICES 150
9.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET 150
9.14 PERSONAL CARE DEVICES 152
9.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET 152
9.15 NEUROLOGY DEVICES 154
9.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES TO DRIVE MARKET 154
9.16 PATIENT MONITORING DEVICES 156
9.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET 156
9.17 PATIENT ASSISTIVE DEVICES 158
9.17.1 RISING GERIATRIC POPULATION TO PROPEL MARKET 158
9.18 OTHER DEVICES 159

10 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS 161
10.1 INTRODUCTION 162
10.2 CLASS II MEDICAL DEVICES 162
10.2.1 BROAD DEVICE APPLICATIONS AND HIGH UTILIZATION TO DRIVE MARKET GROWTH 162
10.3 CLASS I MEDICAL DEVICES 165
10.3.1 HIGH-VOLUME DEMAND FOR CLASS I DEVICES TO SUPPORT MARKET GROWTH 165
10.4 CLASS III MEDICAL DEVICES 167
10.4.1 RISING DEMAND FOR HIGH-RISK AND TECHNOLOGICALLY ADVANCED DEVICES TO DRIVE SEGMENT GROWTH 167

11 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE 169
11.1 INTRODUCTION 170
11.2 DEVICE DEVELOPMENT & MANUFACTURING SERVICES 171
11.2.1 DEVICE & COMPONENT MANUFACTURING SERVICES 173
11.2.1.1 Growing demand for specialized manufacturing capabilities to drive growth 173
11.2.2 PROCESS DEVELOPMENT SERVICES 175
11.2.2.1 Increasing product complexity and regulatory requirements to drive demand 175
11.2.3 DEVICE ENGINEERING SERVICES 177
11.2.3.1 Increasing device complexity to drive demand for engineering services 177
11.3 QUALITY MANAGEMENT SERVICES 179
11.3.1 PACKAGING VALIDATION SERVICES 181
11.3.1.1 Increasing product safety requirements to drive demand 181
11.3.2 INSPECTION & TESTING SERVICES 182
11.3.2.1 Growing regulatory requirements and device complexity to drive demand 182
11.3.3 STERILIZATION SERVICES 184
11.3.3.1 Rising complexity of sterility standards to augment market 184
11.4 PACKAGING & ASSEMBLY SERVICES 186
11.4.1 PRIMARY & SECONDARY PACKAGING SERVICES 188
11.4.1.1 Growing concerns for patient safety to aid segment 188
11.4.2 LABELING SERVICES 189
11.4.2.1 Increasing regulatory requirements and traceability needs to drive demand 189
11.4.3 OTHER PACKAGING & ASSEMBLY SERVICES 191
11.5 OTHER SERVICES 192

12 BY REGION 193
12.1 INTRODUCTION 194
12.2 NORTH AMERICA 195
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 195
12.2.2 US 199
12.2.2.1 Presence of stringent government regulations to drive market 199
12.2.3 CANADA 203
12.2.3.1 Strong presence of key contract manufacturing companies to augment market 203
12.3 EUROPE 207
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 208
12.3.2 GERMANY 212
12.3.2.1 Presence of major device manufacturers and high healthcare expenditure to support market growth 212
12.3.3 UK 216
12.3.3.1 Rising number of accredited clinical laboratories and hospital laboratories to propel market 216
12.3.4 FRANCE 220
12.3.4.1 Increasing government pressure for healthcare cost reduction and budgetary constraints to support market growth 220
12.3.5 SPAIN 224
12.3.5.1 Increasing adoption of home-based medical devices to drive market 224
12.3.6 ITALY 228
12.3.6.1 Healthcare coverage for all citizens and foreign residents to increase demand for medical devices 228
12.3.7 REST OF EUROPE 232
12.4 ASIA PACIFIC 235
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 235
12.4.2 CHINA 240
12.4.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market 240
12.4.3 INDIA 245
12.4.3.1 Rising contract manufacturing capabilities to support market growth 245
12.4.4 JAPAN 249
12.4.4.1 Universal healthcare reimbursement policies to propel market 249
12.4.5 MALAYSIA 253
12.4.5.1 Increasing R&D activities and investments by established players to augment market growth 253
12.4.6 THAILAND 257
12.4.6.1 Government-supported industrial clustering and export competitiveness to propel market 257
12.4.7 SOUTH KOREA 261
12.4.7.1 High-value imports from other countries to offer growth opportunities 261
12.4.8 AUSTRALIA 265
12.4.8.1 Government-backed investment in sovereign capability to drive medtech manufacturing growth 265
12.4.9 PHILIPPINES 269
12.4.9.1 Skilled labor force and IT-enabled support to drive market growth 269
12.4.10 SINGAPORE 273
12.4.10.1 Strong government support and global investments to drive market 273
12.4.11 NEW ZEALAND 277
12.4.11.1 Deregulation of therapeutic products unlocking expedited access and export potential 277
12.4.12 REST OF ASIA PACIFIC 281
12.5 LATIN AMERICA 284
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 284
12.5.2 BRAZIL 289
12.5.2.1 Favorable government initiatives and willingness to pay for better healthcare to boost market 289
12.5.3 MEXICO 293
12.5.3.1 Proximity to US and other LATAM countries to strengthen Mexico’s relevance as contract manufacturing hub 293
12.5.4 REST OF LATIN AMERICA 297
12.6 MIDDLE EAST & AFRICA 300
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 300
12.6.2 GCC COUNTRIES 304
12.6.2.1 Kingdom of Saudi Arabia (KSA) 308
12.6.2.1.1 Focus on healthcare localization and Vision 2030 to drive investment 308
12.6.2.2 United Arab Emirates (UAE) 311
12.6.2.2.1 Advanced infrastructure and regulatory efficiency to attract global medtech contract manufacturers 311
12.6.2.3 Rest of GCC Countries 315
12.6.3 REST OF MIDDLE EAST & AFRICA 318

13 COMPETITIVE LANDSCAPE 322
13.1 INTRODUCTION 322
13.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN THE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 322
13.2 REVENUE ANALYSIS, 2023–2025 324
13.3 GLOBAL MARKET SHARE ANALYSIS, 2025 324
13.3.1 US MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SHARE ANALYSIS, 2025 327
13.3.2 EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SHARE ANALYSIS, 2025 328
13.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 329
13.4.1 STARS 329
13.4.2 EMERGING LEADERS 329
13.4.3 PERVASIVE PLAYERS 329
13.4.4 PARTICIPANTS 329
13.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 331
13.4.5.1 Company footprint 331
13.4.5.2 Region footprint 332
13.4.5.3 Device type footprint 333
13.4.5.4 Service footprint 334
13.4.5.5 Device class footprint 335
13.5 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025 335
13.5.1 PROGRESSIVE COMPANIES 335
13.5.2 RESPONSIVE COMPANIES 335
13.5.3 DYNAMIC COMPANIES 336
13.5.4 STARTING BLOCKS 336
13.5.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2025 337
13.5.5.1 List of start-ups/SMEs 337
13.5.5.2 Competitive benchmarking of start-ups/SMEs 338
13.6 COMPANY VALUATION & FINANCIAL METRICS 339
13.6.1 FINANCIAL METRICS 339
13.6.2 COMPANY EVALUATION 339
13.7 R&D ASSESSMENT OF KEY PLAYERS 340
13.8 PRODUCT/BRAND COMPARISON 341
13.9 COMPETITIVE SCENARIO 342

14 COMPANY PROFILES 345
14.1 KEY PLAYERS 345
14.1.1 JABIL INC. 345
14.1.1.1 Business overview 345
14.1.1.2 Products & services offered 346
14.1.1.3 Recent developments 348
14.1.1.3.1 Product approvals 348
14.1.1.3.2 Deals 349
14.1.1.3.3 Expansions 350
14.1.1.4 MnM view 351
14.1.1.4.1 Right to win 351
14.1.1.4.2 Strategic choices 351
14.1.1.4.3 Weaknesses & competitive threats 351
14.1.2 FLEX LTD. 352
14.1.2.1 Business overview 352
14.1.2.2 Products & services offered 354
14.1.2.3 Recent developments 354
14.1.2.3.1 Deals 354
14.1.2.3.2 Expansions 355
14.1.2.4 MnM view 355
14.1.2.4.1 Right to win 355
14.1.2.4.2 Strategic choices 355
14.1.2.4.3 Weaknesses & competitive threats 356
14.1.3 PLEXUS CORP. 357
14.1.3.1 Business overview 357
14.1.3.2 Products & services offered 359
14.1.3.3 Recent developments 359
14.1.3.3.1 Expansions 359
14.1.3.4 MnM view 360
14.1.3.4.1 Right to win 360
14.1.3.4.2 Strategic choices 360
14.1.3.4.3 Weaknesses & competitive threats 360
14.1.4 SANMINA CORPORATION 361
14.1.4.1 Business overview 361
14.1.4.2 Products & services offered 362
14.1.4.3 Recent developments 363
14.1.4.3.1 Deals 363
14.1.4.4 MnM view 363
14.1.4.4.1 Right to win 363
14.1.4.4.2 Strategic choices 363
14.1.4.4.3 Weaknesses & competitive threats 364
14.1.5 INTEGER HOLDINGS CORPORATION 365
14.1.5.1 Business overview 365
14.1.5.2 Products & services offered 366
14.1.5.3 Recent developments 369
14.1.5.3.1 Deals 369
14.1.5.3.2 Expansions 370
14.1.5.4 MnM view 371
14.1.5.4.1 Right to win 371
14.1.5.4.2 Strategic choices 371
14.1.5.4.3 Weaknesses & competitive threats 371
14.1.6 TE CONNECTIVITY LTD. 372
14.1.6.1 Business overview 372
14.1.6.2 Products & services offered 373
14.1.6.3 Recent developments 375
14.1.6.3.1 Product launches 375
14.1.7 CELESTICA INC. 376
14.1.7.1 Business overview 376
14.1.7.2 Products & services offered 378
14.1.7.3 Recent developments 379
14.1.7.3.1 Expansions 379
14.1.7.3.2 Other developments 379
14.1.8 WEST PHARMACEUTICAL SERVICES, INC. 380
14.1.8.1 Business overview 380
14.1.8.2 Products & services offered 381
14.1.8.3 Recent developments 382
14.1.8.3.1 Product launches 382
14.1.8.3.2 Deals 383
14.1.8.3.3 Expansions 383
14.1.9 BENCHMARK ELECTRONICS INC. 384
14.1.9.1 Business overview 384
14.1.9.2 Products & services offered 385
14.1.9.3 Recent developments 387
14.1.9.3.1 Deals 387
14.1.9.3.2 Expansions 387
14.1.10 APTAR 388
14.1.10.1 Business overview 388
14.1.10.2 Products & services offered 389
14.1.10.3 Recent developments 390
14.1.10.3.1 Product launches 390
14.1.10.3.2 Deals 391
14.1.10.3.3 Expansions 393
14.1.11 GERRESHEIMER AG 394
14.1.11.1 Business overview 394
14.1.11.2 Products & services offered 395
14.1.11.3 Recent developments 397
14.1.11.3.1 Deals 397
14.1.12 KIMBALL ELECTRONICS, INC. 398
14.1.12.1 Business overview 398
14.1.12.2 Products & services offered 399
14.1.12.3 Recent developments 400
14.1.12.3.1 Deals 400
14.1.12.3.2 Expansions 401
14.1.13 NORTECH SYSTEMS, INC. 402
14.1.13.1 Business overview 402
14.1.13.2 Products & services offered 403
14.1.13.3 Recent developments 404
14.1.13.3.1 Other developments 404
14.1.14 CARCLO PLC 405
14.1.14.1 Business overview 405
14.1.14.2 Products & services offered 406
14.1.15 NOLATO GW, INC. (A PART OF NOLATO AB) 407
14.1.15.1 Business overview 407
14.1.15.2 Products & services offered 409
14.1.15.3 Recent developments 409
14.1.15.3.1 Deals 409
14.2 OTHER PLAYERS 410
14.2.1 NEMERA 410
14.2.2 VIANT MEDICAL HOLDINGS, INC. 411
14.2.3 TECOMET, INC. 412
14.2.4 SMC LTD. 414
14.2.5 PHILLIPS-MEDISIZE CORPORATION 415
14.2.6 TESSY PLASTICS CORP. 416
14.2.7 MEHOW 417
14.2.8 TEKNI-PLEX 419
14.2.9 CIRTEC MEDICAL 420
14.2.10 PETER’S TECHNOLOGY 421

15 RESEARCH METHODOLOGY 423
15.1 RESEARCH DATA 423
15.1.1 SECONDARY SOURCES 424
15.1.1.1 Key data from secondary sources 425
15.1.2 PRIMARY SOURCES 425
15.1.2.1 Key data from primary sources 427
15.1.2.2 Key industry insights 428
15.2 MARKET SIZE ESTIMATION 430
15.2.1 APPROACH 1: SUPPLY-SIDE ANALYSIS 430
15.2.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 432
15.2.3 APPROACH 3: PARENT MARKET APPROACH – MEDICAL DEVICES MARKET 432
15.2.4 APPROACH 4: COGS APPROACH 432
15.3 MARKET BREAKDOWN & DATA TRIANGULATION 436
15.4 MARKET SHARE ESTIMATION 437
15.5 STUDY ASSUMPTIONS 437
15.6 RISK ASSESSMENT 437
15.7 LIMITATIONS 438
15.7.1 METHODOLOGY-RELATED LIMITATIONS 438
15.7.2 SCOPE-RELATED LIMITATIONS 438

16 APPENDIX 439
16.1 DISCUSSION GUIDE 439
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 446
16.3 CUSTOMIZATION OPTIONS 448
16.3.1 SERVICE/PRODUCT ANALYSIS 448
16.3.2 COMPANY INFORMATION 448
16.3.3 GEOGRAPHIC ANALYSIS 448
16.3.4 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT 448
16.3.5 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 448
16.4 RELATED REPORTS 449
16.5 AUTHOR DETAILS 450

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SEGMENTATION & REGIONAL SCOPE 39.
FIGURE 2 MARKET SCENARIO 43.
FIGURE 3 GLOBAL MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2024–2031 44.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023–2025 45.
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 45.
FIGURE 6 HIGH-GROWTH SEGMENTS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2026–2031 46.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 47.
FIGURE 8 EMERGING ECONOMIES TO OFFER HIGH-GROWTH OPPORTUNITIES FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 49.
FIGURE 9 DEVICE DEVELOPMENT & MANUFACTURING SERVICES AND CHINA DOMINATED MARKET IN 2025 50.
FIGURE 10 APAC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51.
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51.
FIGURE 12 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 52.
FIGURE 13 MARKET DYNAMICS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 54.
FIGURE 14 GDP GROWTH FORECAST: COMPARISON OF INDIA, CHINA, US, AND GERMANY, 2022 VS. 2030 (FORECAST) 55.
FIGURE 15 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING 58.
FIGURE 16 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2022) 61.
FIGURE 17 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 66.
FIGURE 18 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: VALUE CHAIN ANALYSIS 74.
FIGURE 19 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS 75.
FIGURE 20 AVERAGE SELLING PRICE TREND IN MEDICAL DEVICE CONTRACT MANUFACTURING (DRUG DELIVERY DEVICES, CARDIOVASCULAR DEVICES, AND IVD DEVICES), BY REGION, 2025 78.
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81.
FIGURE 22 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2021–2025 82.
FIGURE 23 AI USE CASES 94.
FIGURE 24 KEY STAKEHOLDERS IN BUYING PROCESS FOR MEDICAL DEVICE CONTRACT MANUFACTURING, BY DEVICE CLASS 105.
FIGURE 25 KEY BUYING CRITERIA, BY CLASS OF DEVICE 106.
FIGURE 26 US: NUMBER OF CASES OF SEXUALLY TRANSMITTED DISEASES, 2023 VS. 2024 150.
FIGURE 27 DISTRIBUTION OF GLOBAL UNIQUE DEVICE IDENTIFICATION DATABASE (GUDID) RECORDS, BY DEVICE CLASS, 2025 163.
FIGURE 28 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES 170.
FIGURE 29 DEVICE PROCESS DEVELOPMENT SERVICES 175.
FIGURE 30 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES 186.
FIGURE 31 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 194.
FIGURE 32 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT 195.
FIGURE 33 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT 236.
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2023–2025) 324.
FIGURE 35 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SHARE ANALYSIS, 2025 325.
FIGURE 36 US MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SHARE ANALYSIS, 2025 327.
FIGURE 37 EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SHARE ANALYSIS, 2025 328.
FIGURE 38 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 330.
FIGURE 39 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY FOOTPRINT 331.
FIGURE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2025 336.
FIGURE 41 EV/EBITDA OF KEY VENDORS 339.
FIGURE 42 5-YEAR STOCK BETA OF KEY VENDORS 339.
FIGURE 43 R&D ASSESSMENT OF KEY PLAYERS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023–2025 340.
FIGURE 44 BRAND/PRODUCT COMPARATIVE ANALYSIIS 341.
FIGURE 45 JABIL INC.: COMPANY SNAPSHOT (2025) 346.
FIGURE 46 FLEX LTD.: COMPANY SNAPSHOT (2025) 353.
FIGURE 47 PLEXUS CORP.: COMPANY SNAPSHOT (2025) 358.
FIGURE 48 SANMINA CORPORATION: COMPANY SNAPSHOT (2025) 362.
FIGURE 49 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 366.
FIGURE 50 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2025) 373.
FIGURE 51 CELESTICA INC.: COMPANY SNAPSHOT (2025) 377.
FIGURE 52 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2025) 381.
FIGURE 53 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2025) 385.
FIGURE 54 APTAR: COMPANY SNAPSHOT (2025) 389.
FIGURE 55 GERRESHEIMER AG: COMPANY SNAPSHOT (2025) 395.
FIGURE 56 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2025) 399.
FIGURE 57 NORTECH SYSTEMS, INC.: COMPANY SNAPSHOT (2025) 403.
FIGURE 58 CARCLO PLC: COMPANY SNAPSHOT (2025) 406.
FIGURE 59 NOLATO GW, INC.: COMPANY SNAPSHOT (2025) 408.
FIGURE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: RESEARCH DESIGN 423.
FIGURE 61 PRIMARY SOURCES 426.
FIGURE 62 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 428.
FIGURE 63 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 429.
FIGURE 64 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 429.
FIGURE 65 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 430.
FIGURE 66 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD. 431.
FIGURE 67 SUPPLY-SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2024) 431.
FIGURE 68 DEMAND-SIDE ESTIMATION FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 433.
FIGURE 69 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 434.
FIGURE 70 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 434.
FIGURE 71 TOP-DOWN APPROACH 435.
FIGURE 72 MARKET DATA TRIANGULATION METHODOLOGY 436.
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 41.
TABLE 2 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050 62.
TABLE 3 UNMET CUSTOMER NEEDS & WHITE SPACES IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 64.
TABLE 4 +INTERCONNECTED MARKETS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 64.
TABLE 5 CROSS-SECTOR MARKETS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 65.
TABLE 6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 67.
TABLE 7 GDP, CURRENT PRICES, 2021–2030 (USD BILLION) 70.
TABLE 8 AVERAGE SELLING PRICE TREND IN MEDICAL DEVICE CONTRACT MANUFACTURING (DRUG DELIVERY DEVICES, CARDIOVASCULAR DEVICES, AND IVD DEVICES), BY KEY PLAYER, 2023–2025 75.
TABLE 9 AVERAGE SELLING PRICE TREND OF DRUG DELIVERY DEVICES, BY REGION, 2023−2025 (USD) 76.
TABLE 10 AVERAGE SELLING PRICE TREND OF IVD DEVICES, BY REGION, 2023−2025 (USD) 77.
TABLE 11 AVERAGE SELLING PRICE TREND OF CARDIOVASCULAR DEVICES, BY REGION, 2023−2025 (USD) 77.
TABLE 12 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 79.
TABLE 13 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 80.
TABLE 14 DETAILED LIST OF CONFERENCES & EVENTS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2026–2027 80.
TABLE 15 US IMPORTS AND APPLICABLE TARIFF FRAMEWORK BY COUNTRY (2025–2026) 84.
TABLE 16 KEY PRODUCT-RELATED TARIFFS EFFECTIVE MEDICAL DEVICES 85.
TABLE 17 NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA 86.
TABLE 18 ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA 86.
TABLE 19 EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK 87.
TABLE 20 LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO 88.
TABLE 21 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: TECHNOLOGY/PRODUCT ROADMAP 91.
TABLE 22 KEY COMPANIES IMPLEMENTING AI IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 95.
TABLE 23 US: CLASSIFICATION OF MEDICAL EQUIPMENT 96.
TABLE 24 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 96.
TABLE 25 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 97.
TABLE 26 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 98.
TABLE 27 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 99.
TABLE 28 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 99.
TABLE 29 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100.
TABLE 30 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100.
TABLE 31 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101.
TABLE 32 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101.
TABLE 33 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102.
TABLE 34 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%), BY DEVICE CLASS 106.
TABLE 35 KEY BUYING CRITERIA, BY CLASS OF DEVICE 107.
TABLE 36 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 112.
TABLE 37 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 114.
TABLE 38 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 114.
TABLE 39 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 116.
TABLE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 118.
TABLE 41 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 120.
TABLE 42 PREVALENCE OF CVDS, 2015–2035 122.
TABLE 43 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 44 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 124.
TABLE 45 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 124.
TABLE 46 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR INFUSION DEVICES & ADMINISTRATION SETS, BY COUNTRY, 2024–2031 (USD MILLION) 126.
TABLE 47 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SYRINGES, BY COUNTRY, 2024–2031 (USD MILLION) 128.
TABLE 48 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR INHALERS, BY COUNTRY, 2024–2031 (USD MILLION) 130.
TABLE 49 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY 131.
TABLE 50 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR AUTOINJECTORS, BY COUNTRY, 2024–2031 (USD MILLION) 132.
TABLE 51 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PEN INJECTORS, BY COUNTRY, 2024–2031 (USD MILLION) 133.
TABLE 52 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DRUG DELIVERY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 135.
TABLE 53 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 137.
TABLE 54 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 139.
TABLE 55 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 141.
TABLE 57 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 143.
TABLE 58 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETIC PATIENTS (20–79 YRS) (2024 VS. 2050) 144.
TABLE 59 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 145.
TABLE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DENTAL DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 147.
TABLE 61 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ENDOSCOPY & LAPAROSCOPY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 149.
TABLE 62 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR GYNECOLOGY/UROLOGY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 151.
TABLE 63 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 153.
TABLE 64 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 155.
TABLE 65 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 157.
TABLE 66 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 158.
TABLE 67 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 160.
TABLE 68 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 162.
TABLE 69 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 164.
TABLE 70 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 166.
TABLE 71 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 168.
TABLE 72 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 170.
TABLE 73 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 171.
TABLE 74 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 172.
TABLE 76 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE & COMPONENT MANUFACTURING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 174.
TABLE 77 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PROCESS DEVELOPMENT SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 176.
TABLE 78 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE ENGINEERING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 178.
TABLE 79 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 180.
TABLE 80 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 180.
TABLE 81 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING VALIDATION SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 181.
TABLE 82 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR INSPECTION & TESTING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 183.
TABLE 83 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE 184.
TABLE 84 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR STERILIZATION SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 185.
TABLE 85 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 186.
TABLE 86 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 187.
TABLE 87 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PRIMARY & SECONDARY PACKAGING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 188.
TABLE 88 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR LABELING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 190.
TABLE 89 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER PACKAGING & ASSEMBLY SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 191.
TABLE 90 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 192.
TABLE 91 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2024–2031 (USD MILLION) 194.
TABLE 92 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196.
TABLE 93 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 196.
TABLE 94 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 197.
TABLE 95 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 197.
TABLE 96 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 198.
TABLE 97 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 198.
TABLE 98 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 99 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 100 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 101 US: KEY MACROINDICATORS 200.
TABLE 102 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 200.
TABLE 103 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 201.
TABLE 104 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 201.
TABLE 105 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 202.
TABLE 106 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 202.
TABLE 107 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 202.
TABLE 108 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 109 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 110 CANADA: KEY MACROINDICATORS 204.
TABLE 111 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 204.
TABLE 112 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 113 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 205.
TABLE 114 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 206.
TABLE 115 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 206.
TABLE 116 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 206.
TABLE 117 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 118 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 119 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208.
TABLE 120 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 209.
TABLE 121 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 122 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 210.
TABLE 123 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 210.
TABLE 124 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 210.
TABLE 125 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 126 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 127 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 128 GERMANY: KEY MACROINDICATORS 212.
TABLE 129 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 213.
TABLE 130 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 213.
TABLE 131 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 214.
TABLE 132 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 214.
TABLE 133 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 214.
TABLE 134 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 135 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 136 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 137 UK: KEY MACROINDICATORS 216.
TABLE 138 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 217.
TABLE 139 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 217.
TABLE 140 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 218.
TABLE 141 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 218.
TABLE 142 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 218.
TABLE 143 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 144 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 145 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 146 FRANCE: KEY MACROINDICATORS 220.
TABLE 147 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 221.
TABLE 148 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 221.
TABLE 149 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 222.
TABLE 150 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 222.
TABLE 151 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 222.
TABLE 152 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 153 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 154 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 155 SPAIN: KEY MACROINDICATORS 224.
TABLE 156 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 225.
TABLE 157 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 225.
TABLE 158 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 226.
TABLE 159 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 226.
TABLE 160 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 226.
TABLE 161 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 162 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 163 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 227.
TABLE 164 ITALY: KEY MACROINDICATORS 228.
TABLE 165 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 229.
TABLE 166 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 229.
TABLE 167 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 230.
TABLE 168 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 230.
TABLE 169 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 230.
TABLE 170 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 171 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 172 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 173 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 232.
TABLE 174 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 233.
TABLE 175 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 233.
TABLE 176 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 233.
TABLE 177 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 234.
TABLE 178 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 234.
TABLE 179 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 234.
TABLE 180 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 235.
TABLE 181 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 237.
TABLE 182 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 237.
TABLE 183 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 184 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 238.
TABLE 185 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 239.
TABLE 186 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 239.
TABLE 187 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 239.
TABLE 188 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 240.
TABLE 189 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 240.
TABLE 190 CHINA: KEY MACROINDICATORS 241.
TABLE 191 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 242.
TABLE 192 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 242.
TABLE 193 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 243.
TABLE 194 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 243.
TABLE 195 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 243.
TABLE 196 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 244.
TABLE 197 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 244.
TABLE 198 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 244.
TABLE 199 INDIA: KEY MACROINDICATORS 245.
TABLE 200 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 246.
TABLE 201 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 246.
TABLE 202 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 247.
TABLE 203 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 247.
TABLE 204 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 247.
TABLE 205 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 248.
TABLE 206 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 248.
TABLE 207 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 248.
TABLE 208 JAPAN: KEY MACROINDICATORS 249.
TABLE 209 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 250.
TABLE 210 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 250.
TABLE 211 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 251.
TABLE 212 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 251.
TABLE 213 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 251.
TABLE 214 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 252.
TABLE 215 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 252.
TABLE 216 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 252.
TABLE 217 MALAYSIA: KEY MACROINDICATORS 253.
TABLE 218 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 254.
TABLE 219 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 254.
TABLE 220 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 255.
TABLE 221 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 255.
TABLE 222 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 255.
TABLE 223 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 256.
TABLE 224 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 256.
TABLE 225 MALAYSIA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 256.
TABLE 226 THAILAND: KEY MACROINDICATORS 257.
TABLE 228 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 258.
TABLE 229 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 258.
TABLE 230 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2024–2031 (USD MILLION) 259.
TABLE 231 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS, 2024–2031 (USD MILLION) 259.
TABLE 232 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024–2031 (USD MILLION) 259.
TABLE 233 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 260.
TABLE 234 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 260.
TABLE 235 THAILAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2024–2031 (USD MILLION) 260.
TABLE 236 SOUTH KOREA: KEY MACROINDICATORS 261.
TABLE 237 SOUTH KOREA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024–2031 (USD MILLION) 262.
TABLE 238 SOUTH KOREA:MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2024–2031 (USD MILLION) 262.